What are the primary investigators (physicians) at the fifteen plus trial sites who are using Leronlimab as an open label doing to get the word out to the public at large?
Granted they just completed a double blinded study, but nothing is stopping them from talking about their experience using Leronlimab on an open label basis.
At a certain point their collective experience in the trenches becomes more than anecdotal.